ePedigree Software

ePedigree Software

Global ePedigree Software Market to Reach US$8.8 Billion by 2030

The global market for ePedigree Software estimated at US$2.9 Billion in the year 2023, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 17.4% over the analysis period 2023-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Cloud Deployment segment is estimated at 18.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$783.8 Million While China is Forecast to Grow at 22.8% CAGR

The ePedigree Software market in the U.S. is estimated at US$783.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 22.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.2% and 15.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.

Global ePedigree Software Market - Key Trends & Drivers Summarized

Why Is ePedigree Software Essential for Pharmaceutical Supply Chains?

ePedigree software is becoming increasingly essential for pharmaceutical supply chains, providing a critical tool for tracking and verifying the authenticity of drugs as they move from manufacturers to consumers. This software helps ensure compliance with regulations that require a detailed record of the distribution history of pharmaceutical products, known as an electronic pedigree or ePedigree. By maintaining a secure and transparent record of each transaction in the supply chain, ePedigree software helps to prevent the distribution of counterfeit drugs, protect public health, and ensure that consumers receive safe and effective medications. As regulatory requirements become more stringent, the role of ePedigree software in safeguarding the pharmaceutical supply chain is becoming more vital.

How Are Technological Innovations Enhancing ePedigree Software?

Technological advancements are playing a significant role in enhancing the capabilities of ePedigree software, making it more robust, secure, and user-friendly. The integration of blockchain technology into ePedigree systems is revolutionizing the way pharmaceutical products are tracked, providing an immutable and transparent ledger that enhances security and prevents tampering. Additionally, the use of cloud-based platforms is offering greater scalability and accessibility, allowing organizations to manage their ePedigree records more efficiently and from any location. The incorporation of AI and machine learning into ePedigree software is also improving the accuracy of tracking and verification processes, enabling real-time monitoring and predictive analytics that can help identify potential issues before they impact the supply chain.

What Industry Trends Are Driving the Adoption of ePedigree Software?

Several industry trends are driving the adoption of ePedigree software, particularly the increasing focus on drug safety, the rising incidence of counterfeit drugs, and the tightening of regulatory requirements. The growing concern over drug safety and the need to protect public health are significant drivers, as organizations seek to ensure that their products are authentic and have not been tampered with during distribution. The rise in counterfeit drugs, which poses a serious threat to consumer safety, is also contributing to the demand for ePedigree software that can provide a secure and transparent record of a drug`s journey through the supply chain. Additionally, stricter regulatory requirements, particularly in regions like the United States and Europe, are driving the need for compliant ePedigree solutions that can meet the demands of the pharmaceutical industry.

What Are the Key Drivers Behind the Growth of the ePedigree Software Market?

The growth in the ePedigree software market is driven by several factors, including the increasing focus on drug safety and security, the rise of counterfeit drugs, and the need to comply with stringent regulatory requirements. The growing emphasis on ensuring the safety and authenticity of pharmaceutical products is a major driver, as organizations seek to protect consumers and maintain their reputations. The increasing incidence of counterfeit drugs is also fueling demand for ePedigree software, as the need for secure and transparent tracking systems becomes more critical. Additionally, the tightening of regulatory requirements around the world is driving the adoption of ePedigree software, as pharmaceutical companies must comply with complex rules to ensure the integrity of their supply chains. The continuous innovation in blockchain, AI, and cloud technologies is further propelling market growth by enhancing the capabilities and accessibility of ePedigree solutions.

Select Competitors (Total 52 Featured) -

• Bar Code Integrators Inc. (BCI)
• Cargoz FZE
• Datex Corporation
• DCAA Solutions
• Dynasty Pharmaceuticals Inc.
• Intellicon Private Limited
• Labeling System, LLC.
• SpiraTec AG
• Tracelink Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.